May Sabry

411 total citations
11 papers, 351 citations indexed

About

May Sabry is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, May Sabry has authored 11 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Oncology and 3 papers in Hematology. Recurrent topics in May Sabry's work include Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (4 papers) and T-cell and B-cell Immunology (4 papers). May Sabry is often cited by papers focused on Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (4 papers) and T-cell and B-cell Immunology (4 papers). May Sabry collaborates with scholars based in United Kingdom, Hungary and United States. May Sabry's co-authors include Mark W. Lowdell, Robert Garofalo, Robert K. Yu, Antonella Casola, Allan R. Brasier, P. L. Ogra, Meghavi Mashar, Janet North, Stephen Mackinnon and Simon Hood and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

May Sabry

9 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
May Sabry United Kingdom 8 240 130 91 60 41 11 351
Timothy Polak United States 11 299 1.2× 113 0.9× 45 0.5× 104 1.7× 70 1.7× 12 495
Lauren J. Howson Australia 9 282 1.2× 76 0.6× 67 0.7× 38 0.6× 60 1.5× 15 400
Mariana Resende Portugal 10 227 0.9× 83 0.6× 46 0.5× 19 0.3× 52 1.3× 15 381
Elaine O Costelloe Australia 8 211 0.9× 66 0.5× 53 0.6× 43 0.7× 139 3.4× 8 387
Paulo Cordeiro Canada 15 230 1.0× 75 0.6× 107 1.2× 12 0.2× 49 1.2× 30 395
Yuko Yuki United States 7 307 1.3× 50 0.4× 90 1.0× 18 0.3× 111 2.7× 11 497
Ervand Kristosturyan United States 5 211 0.9× 100 0.8× 38 0.4× 23 0.4× 100 2.4× 6 383
Christopher Trindade United States 5 208 0.9× 112 0.9× 116 1.3× 17 0.3× 81 2.0× 9 396
Asha Jayakumar United States 9 149 0.6× 133 1.0× 46 0.5× 16 0.3× 58 1.4× 10 325
Timo Rückert Germany 10 334 1.4× 67 0.5× 95 1.0× 10 0.2× 71 1.7× 11 443

Countries citing papers authored by May Sabry

Since Specialization
Citations

This map shows the geographic impact of May Sabry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Sabry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Sabry more than expected).

Fields of papers citing papers by May Sabry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May Sabry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Sabry. The network helps show where May Sabry may publish in the future.

Co-authorship network of co-authors of May Sabry

This figure shows the co-authorship network connecting the top 25 collaborators of May Sabry. A scholar is included among the top collaborators of May Sabry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May Sabry. May Sabry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chindera, Kantaraja, May Sabry, Nafisa Wilkinson, et al.. (2024). Natural Killer Cell Dysfunction in Premenopausal BRCA1 Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis. Cancers. 16(6). 1186–1186.
2.
Orchard, Kim, Aljawharah Alrubayyi, R. W. Torrance, et al.. (2024). Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 12(7). e008717–e008717. 9 indexed citations
3.
Sabry, May, et al.. (2023). A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome. Cells. 12(4). 633–633. 7 indexed citations
4.
5.
Sabry, May & Mark W. Lowdell. (2020). Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer. Stem Cells Translational Medicine. 9(9). 974–984. 21 indexed citations
6.
Sabry, May, et al.. (2019). Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures. PLoS ONE. 14(6). e0218674–e0218674. 38 indexed citations
7.
Sabry, May & Mark W. Lowdell. (2013). Tumor-Primed NK Cells: Waiting for the Green Light. Frontiers in Immunology. 4. 408–408. 40 indexed citations
8.
Sabry, May, et al.. (2011). Leukemic Priming of Resting NK Cells Is Killer Ig-like Receptor Independent but Requires CD15-Mediated CD2 Ligation and Natural Cytotoxicity Receptors. The Journal of Immunology. 187(12). 6227–6234. 34 indexed citations
9.
Stipkovits, L., et al.. (2010). Studies on the Pathogenicity of Ureaplasmas in Poultry. Zentralblatt für Veterinärmedizin Reihe B. 25(9). 707–712.
11.
Stipkovits, L., et al.. (1978). Studies on pathogenicity of Turkey ureaplasma. Avian Pathology. 7(4). 577–582. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026